Jordan Eric Axelrad MD MPH

Gastroenterology•New York, NY

Inflammatory Bowel Disease

Associate Professor

Join to View Full Profile

305 East 33rd StreetNew York, NY 10016

Summary

Dr. Jordan Axelrad, based in New York, NY, is a trained gastroenterologist with a subspecialty in Inflammatory Bowel Disease. He completed his fellowship in Gastroenterology at New York Presbyterian Hospital (Columbia Campus) and his residency in Internal Medicine at the Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital. Since 2018, Dr. Axelrad has been working as an Associate Professor at the New York University School of Medicine. He has deep experience with treating conditions like IBD, ulcerative colitis, and Crohn's disease. He has also contributed to various publications in his field, such as the Clinical Gastroenterology and Hepatology and The American Journal of Gastroenterology, on topics related to his specialty.

Education & Training

New York Presbyterian Hospital (Columbia Campus)Fellowship, Gastroenterology, 2015 - 2018
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2012 - 2015
Tufts University School of MedicineClass of 2012

Certifications & Licensure

CT State Medical License 2022 - 2026
FL State Medical License 2022 - 2026
NY State Medical License 2013 - 2026
PA State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

1 citations
Editorial: Resecting Assumptions-Do Proctocolectomy Guidelines Hold Up?
Vasantham Chaudhary, Jordan E Axelrad
Alimentary Pharmacology & Therapeutics. 2025-12-01
1 citations
Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease.
William Schreiber-Stainthorp, Adam S Faye, Jordan E Axelrad
Inflammatory Bowel Diseases. 2025-11-01
Treatment-Free Outcomes Following Surgery for IBD: A Nationwide Cohort Study.
Adam S Faye, Jordan Axelrad, Jiangwei Sun, Jonas Halfvarsson,
Alimentary Pharmacology & Therapeutics. 2025-10-21

Journal Articles

A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data
Jordan Axelrad, MD, Dove Press
Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease
Andrew Joelson, Simon Lichtiger, Jordan E Axelrad, Garrett Lawlor, Benjamin Lebwohl, Nature

Abstracts/Posters

Patients with Inflammatory Bowel Disease and a history of cancer: The risk of cancer following exposure to immunosuppression
Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, Mceachern E, Bosworth B, Scherl E, Reyes A, Zaidi H..., European Crohn's and Colitis Organisation Congress 2015, Barcelona, Spain, 2/20/2015
The risk of incident cancer in patients with Inflammatory Bowel Disease and a history of cancer following immunosuppression exposure
Axelrad J, Bernheim O, Colombel JF, Anathakrishnan A, Yajnik V, Katz S, Malerba S, Itzkowitz S, 2014 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation’s Clinical & Research Conference, Orlando, Florida, 12/3/2014
Clostridium difficile Infection in Inflammatory Bowel Disease: A Nursing Based Quality Improvement Strategy
Axelrad JE, Shah BJ, American College of Gastroenterology annual scientific meeting, Philadelphia, Pennsylvania, 10/21/2014
Trends in the spectrum of engagement in HIV care among men who have sex with men (MSM) at a Boston community health center
Axelrad JE, Mimiaga MJ, Grasso C, Mayer KH, 19th International AIDS Conference, Washington D.C., 7/23/2012
Reduced Purkinje cell number in essential tremor: a postmortem study
Louis ED, Axelrad JE, Honig LS, Flores I, Ross GW, Pahwa R, Lyons KE, Faust PL,Vonsattel JP, Movement Disorder Society’s 11th International Congress of Parkinson's Disease and Movement Disorders, Istanbul, Turkey, 6/7/2007
Join now to see all